Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling
J. Clin. Invest. Julian C. Braz, et al. 111:1475 doi:10.1172/JCI17295 [Go to this article.]

Table 1
Echocardiography of dnp38 transgenic mice at various ages